What is he best known for?
The fields of study he is best known for:
- Cancer
- Internal medicine
- Surgery
His primary areas of investigation include Sarcoma, Surgery, Pathology, Soft tissue sarcoma and Soft tissue.
James M. Woodruff studies Synovial sarcoma which is a part of Sarcoma.
His Surgery research is multidisciplinary, incorporating elements of Radiology and Metastasis.
His Pathology research is multidisciplinary, incorporating perspectives in Internal medicine and Exon.
His Soft tissue sarcoma research is multidisciplinary, relying on both Respiratory disease and Lymph.
His studies in Stromal tumor integrate themes in fields like Gastrointestinal stromal tumors and GiST.
His most cited work include:
- Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. (2118 citations)
- Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities. (956 citations)
- Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. (738 citations)
What are the main themes of his work throughout his whole career to date?
Pathology, Sarcoma, Surgery, Soft tissue sarcoma and Soft tissue are his primary areas of study.
A large part of his Sarcoma studies is devoted to Synovial sarcoma.
The various areas that he examines in his Surgery study include Radiology and Metastasis.
His Radiology research incorporates themes from Dissection and Cohort study.
His work carried out in the field of Soft tissue sarcoma brings together such families of science as Gastroenterology, Survival analysis and Univariate analysis.
His Soft tissue study combines topics from a wide range of disciplines, such as Cancer and Cohort.
He most often published in these fields:
- Pathology (53.51%)
- Sarcoma (42.11%)
- Surgery (31.58%)
What were the highlights of his more recent work (between 1997-2013)?
- Pathology (53.51%)
- Sarcoma (42.11%)
- Surgery (31.58%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Pathology, Sarcoma, Surgery, Immunohistochemistry and Soft tissue sarcoma.
His research combines Cancer research and Pathology.
James M. Woodruff has included themes like Proportional hazards model, Metastasis, Soft tissue and Lung in his Sarcoma study.
Surgery and Multivariate analysis are frequently intertwined in his study.
His Immunohistochemistry research integrates issues from Phenotype, Exact test, Point mutation, Clinical significance and Melanoma.
His work investigates the relationship between Soft tissue sarcoma and topics such as Survival analysis that intersect with problems in Metastasectomy, Spindle cell sarcoma, Respiratory disease, Radiation treatment planning and Brachytherapy.
Between 1997 and 2013, his most popular works were:
- Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. (2118 citations)
- Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. (654 citations)
- SYT–SSX Gene Fusion as a Determinant of Morphology and Prognosis in Synovial Sarcoma (544 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Internal medicine
- Pathology
James M. Woodruff spends much of his time researching Sarcoma, Surgery, Pathology, Synovial sarcoma and Soft tissue sarcoma.
His research in Sarcoma intersects with topics in Fusion gene, Proportional hazards model, Malignant peripheral nerve sheath tumor, Soft tissue and Plexiform neurofibroma.
His Surgery research incorporates elements of Metastasis and Disease.
James M. Woodruff has researched Pathology in several fields, including Internal medicine and Exon.
His biological study spans a wide range of topics, including Hemangiopericytoma, Vascular disease and Histology.
His Soft tissue sarcoma study combines topics in areas such as Cancer, Survival analysis, Annual incidence and Spindle cell sarcoma.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
